{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Adolescent+Asthma&page=4", "query": { "condition": "Adolescent Asthma", "page": 4 }, "page_size": 10 }, "pagination": { "page": 4, "page_size": 10, "total_count": 172, "total_pages": 18, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Adolescent+Asthma&page=5&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Adolescent+Asthma&page=3&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-06T08:32:19.792Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT06572228", "title": "Efficacy of Dupilumab Added to Medium Dose Inhaled Corticosteroid/Long-acting Beta-agonist (ICS/LABA) in Comparison to ICS Dose Escalation to High Dose ICS/LABA in Adolescent and Adult Patients With Uncontrolled Asthma", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "dupilumab", "type": "DRUG" }, { "name": "Matching Placebo", "type": "DRUG" }, { "name": "ICS/LABA", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Regeneron Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "12 Years to 80 Years" }, "enrollment_count": 120, "start_date": "2024-08-26", "completion_date": "2027-04-24", "has_results": false, "last_update_posted_date": "2026-05-22", "last_synced_at": "2026-10-06T08:32:19.792Z", "location_count": 51, "location_summary": "Bakersfield, California • La Jolla, California • Lancaster, California + 47 more", "locations": [ { "city": "Bakersfield", "state": "California" }, { "city": "La Jolla", "state": "California" }, { "city": "Lancaster", "state": "California" }, { "city": "Long Beach", "state": "California" }, { "city": "Newport Beach", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT06572228" }, { "nct_id": "NCT01181895", "title": "Study B2C112060: A Study of the Efficacy and Safety of Vilanterol Inhalation Powder in Adults and Adolescents With Persistent Asthma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "Vilanterol", "type": "DRUG" }, { "name": "Salmeterol Inhalation Powder", "type": "DRUG" }, { "name": "Placebo Inhalation Powder NDPI", "type": "DRUG" }, { "name": "Placebo Inhalation Powder Diskus", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "ALL", "summary": "12 Years and older" }, "enrollment_count": 348, "start_date": "2010-09-01", "completion_date": "2011-08-26", "has_results": true, "last_update_posted_date": "2017-11-08", "last_synced_at": "2026-10-06T08:32:19.792Z", "location_count": 11, "location_summary": "Huntington Beach, California • Orlando, Florida • Tallahassee, Florida + 8 more", "locations": [ { "city": "Huntington Beach", "state": "California" }, { "city": "Orlando", "state": "Florida" }, { "city": "Tallahassee", "state": "Florida" }, { "city": "Lawrenceville", "state": "Georgia" }, { "city": "Skillman", "state": "New Jersey" } ], "official_url": "https://clinicaltrials.gov/study/NCT01181895" }, { "nct_id": "NCT00394199", "title": "Comparison of New Combination Inhaler (FlutiForm HFA MDI 100/10 µg) Versus Fluticasone & Formoterol Administered Alone in Patients With Asthma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "Fluticasone propionate/Formoterol Fumarate 100/10", "type": "DRUG" }, { "name": "Fluticasone propionate 100", "type": "DRUG" }, { "name": "Formoterol fumarate 10", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "SkyePharma AG", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "ALL", "summary": "12 Years and older" }, "enrollment_count": 357, "start_date": "2006-06", "completion_date": "2008-02", "has_results": false, "last_update_posted_date": "2011-06-23", "last_synced_at": "2026-10-06T08:32:19.792Z", "location_count": 29, "location_summary": "Birmingham, Alabama • Mission Viejo, California • Orange, California + 26 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Mission Viejo", "state": "California" }, { "city": "Orange", "state": "California" }, { "city": "San Jose", "state": "California" }, { "city": "Vista", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00394199" }, { "nct_id": "NCT02139644", "title": "Study of Fluticasone Propionate MDPI Compared With Fluticasone/Salmeterol MDPI in Adolescent and Adult Patients With Persistent Asthma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "FS MDPI", "type": "DRUG" }, { "name": "Fp MDPI", "type": "DRUG" }, { "name": "Placebo MDPI", "type": "DRUG" }, { "name": "albuterol/salbutamol", "type": "DRUG" }, { "name": "Beclomethasone dipropionate", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Teva Branded Pharmaceutical Products R&D, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "ALL", "summary": "12 Years and older" }, "enrollment_count": 787, "start_date": "2014-06", "completion_date": "2015-09", "has_results": true, "last_update_posted_date": "2021-11-12", "last_synced_at": "2026-10-06T08:32:19.792Z", "location_count": 76, "location_summary": "Birmingham, Alabama • Glendale, Arizona • Cypress, California + 64 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Glendale", "state": "Arizona" }, { "city": "Cypress", "state": "California" }, { "city": "Encinitas", "state": "California" }, { "city": "Fountain Valley", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02139644" }, { "nct_id": "NCT04719832", "title": "Placebo-controlled Efficacy and Safety Study of GSK3511294 (Depemokimab) in Participants With Severe Asthma With an Eosinophilic Phenotype", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "GSK3511294 (Depemokimab)", "type": "BIOLOGICAL" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "BIOLOGICAL", "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "ALL", "summary": "12 Years and older" }, "enrollment_count": 395, "start_date": "2021-03-17", "completion_date": "2023-11-21", "has_results": true, "last_update_posted_date": "2024-12-17", "last_synced_at": "2026-10-06T08:32:19.792Z", "location_count": 30, "location_summary": "Encinitas, California • Long Beach, California • Pasadena, California + 25 more", "locations": [ { "city": "Encinitas", "state": "California" }, { "city": "Long Beach", "state": "California" }, { "city": "Pasadena", "state": "California" }, { "city": "Rancho Cucamonga", "state": "California" }, { "city": "San Jose", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT04719832" }, { "nct_id": "NCT00073827", "title": "Study of Levalbuterol, Racemic Albuterol and Placebo in Subjects Twelve Years of Age and Older With Asthma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "levalbuterol tartrate MDI", "type": "DRUG" }, { "name": "racemic albuterol MDI", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Sumitomo Pharma America, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "ALL", "summary": "12 Years and older" }, "enrollment_count": 445, "start_date": "2002-05", "completion_date": "2003-01", "has_results": false, "last_update_posted_date": "2012-02-22", "last_synced_at": "2026-10-06T08:32:19.792Z", "location_count": 63, "location_summary": "Homewood, Alabama • Mobile, Alabama • Corona, California + 55 more", "locations": [ { "city": "Homewood", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" }, { "city": "Corona", "state": "California" }, { "city": "Danville", "state": "California" }, { "city": "Encinitas", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00073827" }, { "nct_id": "NCT02498834", "title": "Using Question Prompt Lists During Pediatric Asthma Visits to Increase Adolescent Involvement", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "Educational Video and Question Prompt List", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "University of North Carolina, Chapel Hill", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "11 Years", "maximum_age": "17 Years", "sex": "ALL", "summary": "11 Years to 17 Years" }, "enrollment_count": 359, "start_date": "2015-07", "completion_date": "2017-11", "has_results": true, "last_update_posted_date": "2019-01-16", "last_synced_at": "2026-10-06T08:32:19.792Z", "location_count": 1, "location_summary": "Chapel Hill, North Carolina", "locations": [ { "city": "Chapel Hill", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT02498834" }, { "nct_id": "NCT07772921", "title": "A Study to Learn About the Study Medicine Called Tilrekimig in People With Severe Asthma", "overall_status": "NOT_YET_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "tilrekimig", "type": "DRUG" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "12 Years to 80 Years" }, "enrollment_count": 1100, "start_date": "2026-08-24", "completion_date": "2029-09-04", "has_results": false, "last_update_posted_date": "2026-08-19", "last_synced_at": "2026-10-06T08:32:19.792Z", "location_count": 2, "location_summary": "Garland, Texas • Mesquite, Texas", "locations": [ { "city": "Garland", "state": "Texas" }, { "city": "Mesquite", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT07772921" }, { "nct_id": "NCT04234464", "title": "A Study to Assess the Efficacy of Budesonide/Albuterol Metered-dose Inhaler (BDA MDI/PT027) on Exercise-induced Bronchoconstriction in Adults and Adolescents With Asthma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Exercise Induced Bronchospasm" ], "interventions": [ { "name": "Budesonide/albuterol sulfate metered-dose inhaler 160/180 μg", "type": "COMBINATION_PRODUCT" }, { "name": "Placebo metered-dose inhaler", "type": "COMBINATION_PRODUCT" } ], "intervention_types": [ "COMBINATION_PRODUCT" ], "sponsor": "Bond Avillion 2 Development LP", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "12 Years to 70 Years" }, "enrollment_count": 60, "start_date": "2020-01-15", "completion_date": "2020-08-28", "has_results": true, "last_update_posted_date": "2022-01-13", "last_synced_at": "2026-10-06T08:32:19.792Z", "location_count": 6, "location_summary": "Denver, Colorado • North Dartmouth, Massachusetts • St Louis, Missouri + 3 more", "locations": [ { "city": "Denver", "state": "Colorado" }, { "city": "North Dartmouth", "state": "Massachusetts" }, { "city": "St Louis", "state": "Missouri" }, { "city": "Skillman", "state": "New Jersey" }, { "city": "Raleigh", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT04234464" }, { "nct_id": "NCT01253330", "title": "Usage, Usability & Effect on Adherence and Clinical Outcomes of Text Message Reminders for Adolescents With Asthma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "Text Message Reminders", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Children's Hospital Medical Center, Cincinnati", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": "22 Years", "sex": "ALL", "summary": "12 Years to 22 Years" }, "enrollment_count": 61, "start_date": "2010-11", "completion_date": "2012-12", "has_results": false, "last_update_posted_date": "2016-02-12", "last_synced_at": "2026-10-06T08:32:19.792Z", "location_count": 1, "location_summary": "Cincinnati, Ohio", "locations": [ { "city": "Cincinnati", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT01253330" } ] }